Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin (MK-3102-022)
Clinical trial NCT01704261 · COMPLETED
Trial details
- NCT number
- NCT01704261
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-18
- Primary completion
- 2014-12-23
- Enrollment
- 307
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.